Form 8-K - Current report:
SEC Accession No. 0001193125-24-263447
Filing Date
2024-11-21
Accepted
2024-11-21 16:36:01
Documents
16
Period of Report
2024-11-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d883926d8k.htm   iXBRL 8-K 27931
2 EX-1.1 d883926dex11.htm EX-1.1 188690
3 EX-99.1 d883926dex991.htm EX-99.1 9015
7 GRAPHIC g883926g1120140638463.jpg GRAPHIC 4217
  Complete submission text file 0001193125-24-263447.txt   405214

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA qdel-20241119.xsd EX-101.SCH 2863
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE qdel-20241119_lab.xml EX-101.LAB 17236
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qdel-20241119_pre.xml EX-101.PRE 10821
19 EXTRACTED XBRL INSTANCE DOCUMENT d883926d8k_htm.xml XML 3525
Mailing Address 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121
Business Address 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121 (858) 552-1100
QuidelOrtho Corp (Filer) CIK: 0001906324 (see all company filings)

EIN.: 874496285 | Fiscal Year End: 0101
Type: 8-K | Act: 34 | File No.: 001-41409 | Film No.: 241484964
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)